Snowball logo
logo
EVFM_logo

Evofem Biosciences Inc

EVFM • NASDAQ
$0.007$0.00  (0%)
Estimate
EPS
-0.11
Beta
-1.356
Growth
Revenue, YoY
-45.43%
Net income, YoY
-518.61%
FCF, YoY
-7.5%
About the company
Ticker
EVFM
ISIN
US30048L1044
Country
United States of America
Sector (GICS)
Healthcare
Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. The company's commercial products include PHEXXI, a hormone-free contraceptive vaginal gel; and SOLOSEC, a single-dose oral antimicrobial agent for the treatment of bacterial vaginosis and trichomoniasis. Evofem Biosciences, Inc. is headquartered in San Diego, California.

Frequently asked questions

What sector does Evofem Biosciences Inc (EVFM) operate in?

Evofem Biosciences Inc belongs to the Healthcare sector and operates in the Biotechnology industry.

What is Evofem Biosciences Inc (EVFM) current stock price?

As of the latest data, Evofem Biosciences Inc stock price is $0.01, with a previous close of $0.01.

What is Evofem Biosciences Inc (EVFM) current market capitalization?

Evofem Biosciences Inc market cap is approximately 927.71 thousand.

What is Evofem Biosciences Inc (EVFM) Earnings Per Share (EPS)?

The trailing EPS is -$0.11.

What is Evofem Biosciences Inc (EVFM) EBITDA?

Evofem Biosciences Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -2.44 million.

Does Evofem Biosciences Inc (EVFM) pay dividends?

No. Evofem Biosciences Inc does not pay a dividend.

What is Evofem Biosciences Inc (EVFM) beta (volatility) score?

Evofem Biosciences Inc has a beta of -1.356, indicating lower volatility than the overall market.